# Post-operative Pain Control-TAP Block Using Exparel vs. Marcaine for Hernia Repairs

> **NCT05177991** · EARLY_PHASE1 · ACTIVE_NOT_RECRUITING · sponsor: **Leslie Son** · enrollment: 200 (estimated)

## Conditions studied

- Inguinal Hernia
- Ventral Hernia

## Interventions

- **DRUG:** Liposomal Bupivacaine
- **DRUG:** Bupivacaine

## Key facts

- **NCT ID:** NCT05177991
- **Lead sponsor:** Leslie Son
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2022-03-01
- **Primary completion:** 2024-12-31
- **Final completion:** 2025-12-31
- **Target enrollment:** 200 (ESTIMATED)
- **Last updated:** 2025-09-26

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05177991

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05177991, "Post-operative Pain Control-TAP Block Using Exparel vs. Marcaine for Hernia Repairs". Retrieved via AI Analytics 2026-07-04 from https://api.ai-analytics.org/clinical/NCT05177991. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*